NAD+ vs Epitalon
Both sit in the same longevity and cellular-health category, but they come from almost opposite research traditions — one is a well-established biochemical coenzyme, the other a synthetic peptide built on a mechanism that is still disputed.
At a Glance
| NAD+ | Epitalon | |
|---|---|---|
| Category | Longevity & Cellular Health | Longevity & Cellular Health |
| Molecular class | Coenzyme (dinucleotide) | Synthetic tetrapeptide (Ala-Glu-Asp-Gly) |
| Origin | Naturally occurring cellular coenzyme; biochemistry established since the early 20th century | Synthesized to match Epithalamin, a bovine pineal-gland extract first described by Soviet researchers in 1973 |
| Primary mechanism studied | Electron transport chain cofactor; required cofactor for sirtuin and PARP enzymes | Proposed chromatin-binding effect on gene transcription (disputed hypothesis) |
| Mechanism certainty | Well-established, mainstream biochemistry | Disputed — an active area of research, not a settled mechanism |
| Human trial data | Most human evidence comes from oral precursors (NR, NMN), not direct NAD+ injection | Multi-year human cohort study exists — unusual for a Khavinson-lineage peptide |
| Common research focus | Mitochondrial energy metabolism, DNA repair, sirtuin activation | Telomerase activity, pineal-gland function, cellular aging |
How They Differ
NAD+ is not a peptide at all but a coenzyme — its biochemistry has been characterized since the early 1900s, and its two core roles are well established: shuttling electrons through the mitochondrial electron transport chain to produce ATP, and serving as a required cofactor for the sirtuin and PARP enzyme families involved in gene regulation and DNA repair. The body can also generate NAD+ from precursor molecules like nicotinamide riboside and nicotinamide mononucleotide through the NAD+ salvage pathway, and it's worth noting that most human trial data on raising NAD+ levels comes from studies of those oral precursors rather than NAD+ administered directly. See its full discovery history.
Epitalon is a synthetic tetrapeptide built to match the amino acid sequence found in Epithalamin, a pineal-gland extract Soviet researchers first described in 1973. Unlike NAD+'s settled biochemistry, Epitalon belongs to the Khavinson bioregulator family, whose proposed mechanism — direct chromatin binding that influences gene transcription — remains disputed and unsettled. Its research has focused heavily on telomerase activity and pineal-gland function, and unusually for this compound family, it is backed by a multi-year human cohort study. See its full discovery history, or how it compares to SS-31, or how another Khavinson-lineage peptide compares in our Cartalax vs Pinealon writeup.
Why They're Often Studied Together
NAD+ and Epitalon are grouped together mainly because they're both marketed under the same "longevity" umbrella, not because they share a mechanism or evidence base. Researchers comparing options within cellular-aging research often place a well-characterized metabolic coenzyme next to a peptide with a disputed, gene-regulatory hypothesis specifically to highlight how differently "supports longevity research" can be substantiated from one compound to the next.
NAD+ vs Epitalon questions
Are NAD+ and Epitalon interchangeable in research?
No. They belong to entirely different molecule classes with different mechanisms — NAD+ is a coenzyme with an established biochemical role in energy metabolism and DNA repair, while Epitalon is a synthetic peptide studied for a disputed gene-regulatory effect. They are comparable only in that both are marketed within the longevity and cellular-health category.
Which one has stronger human trial support?
Epitalon has a multi-year human cohort study behind it — unusual among Khavinson-lineage bioregulator peptides. Direct injection of NAD+ itself lacks comparable human trial data; most human evidence for raising NAD+ levels comes from studies of oral precursor molecules like NR and NMN, not NAD+ administered directly.
Does this comparison mean either compound is approved for a particular use?
No. This page compares NAD+ and Epitalon for educational and research context only. Both are sold strictly for laboratory research use and are not evaluated or approved for human or animal use.
Looking for specs and pricing?
View purity, available sizes, and pricing for both.